ROR1 expression is not a unique marker of CLL

被引：56
|
作者：
Barna, Gabor [1 ]
Mihalik, Rudolf [1 ,2 ]
Timar, Botond [1 ]
Toemboel, Judit [1 ]
Csende, Zsolt [3 ]
Sebestyen, Anna [1 ]
Boedoer, Csaba [1 ]
Csernus, Balazs [1 ]
Reiniger, Lilla [1 ]
Petak, Istvan [1 ,2 ]
Matolcsy, Andras [1 ]
机构：
[1] Semmelweis Univ, Fac Med, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Cooperat Res Ctr, H-1085 Budapest, Hungary
[3] Fac Med, Dept Biomech, Budapest, Hungary
来源：
HEMATOLOGICAL ONCOLOGY | 2011年 / 29卷 / 01期
关键词：
CLL; MCL; MZL; ROR1; Wnt; lymphoma; CHRONIC LYMPHOCYTIC-LEUKEMIA; RECEPTOR TYROSINE KINASE; GENE-EXPRESSION; HUMAN CANCER; B-CELLS; MUTATIONS; SCREEN; PROGRESSION; ACTIVATION; PHENOTYPE;
D O I：
10.1002/hon.948
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent studies have identified receptor tyrosine kinase-like orphan receptor 1 (ROR1) on the surface of chronic lymphoid leukaemia (CLL) cells. In order to determine whether ROR1 expression is a suitable surrogate marker for the diagnosis of CLL we analysed the mRNA level of ROR1 in different types of non-Hodgkin lymphomas (NHL), and detected elevated levels of ROR1 compared to control peripheral mononuclear cells in several entities (CLL >= mantle cell lymphoma (MCL) > marginal zone lymphoma (MZL)>> diffuse large B-cell lymphoma > follicular lymphoma). ROR1 protein was expressed intensely on the cell surface of lymphoma cells with leukaemic blood count detected by three colour immunofluorescence. Our results indicate that ROR1 expression is not limited to CLL cases, but it is more prevalent in NHLs, mainly in MCL where it is expressed intensely and MZL where it is expressed moderately, suggesting a general role of ROR1 in lymphoma genesis and/or maintenance. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码：17 / 21
页数：5
相关论文
共 50 条
  • [21] ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells
    Cetin, Metin
    Odabas, Gorkem
    Douglas, Leon R.
    Duriez, Patrick J.
    Balcik-Ercin, Pelin
    Yalim-Camci, Irem
    Sayan, Abdulkadir Emre
    Yagci, Tamer
    CELLS, 2019, 8 (03)
  • [22] The role of Ror1 receptor in cancer
    Lopez Bergami, Pablo
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2011, 45 (04): : 665 - 668
  • [23] ROR1 expression in mature B lymphoid neoplasms by flow cytometry
    de Sousa, Flavia Arandas
    Millan, Nadila Magalhaes
    Correia, Rodolfo Patussi
    Vaz, Andressa da Costa
    Schimidell, Daniela
    Miyamoto, Priscila Carmona
    Passaro, Marilia Sandoval
    Nogueira, Bruna Garcia
    Souto, Elizabeth Xisto
    Bacal, Nydia Strachman
    Bento, Laiz Camerao
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2024, 106 (01) : 74 - 81
  • [24] Heterogeneous Profile of ROR1 Protein Expression across Tumor Types
    Raso, Maria Gabriela
    Toro, Elizve Barrientos
    Evans, Kurt
    Rizvi, Yasmeen
    Lazcano, Rossana
    Akcakanat, Argun
    Sini, Patrizia
    Trapani, Francesca
    Madlener, Eva Johanna
    Waldmeier, Lorenz
    Lazar, Alexander
    Meric-Bernstam, Funda
    CANCERS, 2024, 16 (10)
  • [25] ROR1: an orphan becomes apparent
    Kipps, Thomas J.
    BLOOD, 2022, 140 (14) : 1583 - 1591
  • [26] ROR1 and ROR2-novel targets for neuroblastoma
    Dave, Hema
    Butcher, Donna
    Anver, Miriam
    Bollard, Catherine M.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2019, 36 (06) : 352 - 364
  • [27] Molecular, functional, and gene expression analysis of zebrafish Ror1 receptor
    Bai, Yan
    Liu, Chengdong
    Zhou, Jianfeng
    Rong, Xiaozhi
    Wang, Hongying
    FISH PHYSIOLOGY AND BIOCHEMISTRY, 2019, 45 (01) : 355 - 363
  • [28] A new class of anti-cancer drugs targeting the tyrosine kinase receptor ROR1 in CLL
    Mellstedt, Hakan
    Khan, Salam
    Hojjat-Farsangi, Mohammad
    Daneshmanesh, Amir Hossein
    Vagberg, Jan
    Bystrom, Styrbjorn
    Schultz, Johan
    Norin, Martin
    Olsson, Elisabeth
    Lofberg, Charlotte
    Norstrom, Carina
    Olin, Thomas
    Tsterborg, Anders
    Moshfegh, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] ROR1 Expression Is Associated with Oncogenic Dedifferentiation in Chronic Lymphocytic Leukemia
    Ghia, Emanuela M.
    Choi, Michael Y.
    Widhopf, George F., II
    Rassenti, Laura Z.
    Kipps, Thomas J.
    BLOOD, 2018, 132
  • [30] THE RECEPTOR TYROSINE KINASES ROR1 AND ROR2 EXPRESSION PATTERNS IN LYMPHOID AND MYELOID MALIGNANCIES
    Manesh, A. Danesh
    Porwit, A.
    Hojjat-Farsangi, M.
    Jeddi-Tehrani, M.
    Tamm, K. Pokrovskaja
    Grander, D.
    Lehmann, S.
    Norin, S.
    Shokri, F.
    Rabbani, H.
    Mellstedt, H.
    Osterborg, A.
    HAEMATOLOGICA, 2012, 97 : 520 - 520
12345